1. Home
  2. LEXX vs OBAI Comparison

LEXX vs OBAI Comparison

Compare LEXX & OBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$3.80

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

N/A

Current Price

$0.33

Market Cap

9.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
LEXX
OBAI
Founded
2004
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.7M
9.4M
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
LEXX
OBAI
Price
$3.80
$0.33
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
80.6K
2.4M
Earning Date
04-13-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.53
EPS
N/A
N/A
Revenue
$705,923.00
$9,972,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$601.47
N/A
P/E Ratio
N/A
N/A
Revenue Growth
52.05
2.42
52 Week Low
$0.35
$0.31
52 Week High
$14.37
$19.95

Technical Indicators

Market Signals
Indicator
LEXX
OBAI
Relative Strength Index (RSI) 38.42 34.26
Support Level $0.62 $0.31
Resistance Level $12.89 $0.48
Average True Range (ATR) 1.68 0.04
MACD -0.95 0.01
Stochastic Oscillator 0.11 1.78

Price Performance

Historical Comparison
LEXX
OBAI

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

Share on Social Networks: